Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Description
Skin care is essential for maintaining skin health and preventing skin conditions. It helps to protect the skin from environmental factors, such as UV radiation, pollution, and harsh weather conditions. Proper skin care can also help to manage and alleviate various skin conditions, such as dryness, acne, and dermatitis. Additionally, skin care plays a vital role in wound healing, radiation therapy, and the side effects of certain medications.
The skin care and treatment market in China is projected to rise by USD 79.0 billion by 2029, according to the latest market study results. It is anticipated to expand at a CAGR of 9.88 percent during the forecast period. The demand for skin care products is growing rapidly, driven by factors such as increasing consumer awareness about skincare, rising disposable income, and changing lifestyles. Consumers are becoming more conscious of their skin health and are willing to invest in high-quality skincare products. This increasing demand is fueling the growth of the skin care products market.
Market Segmentation
This industry report offers market estimates of the China market, followed by a detailed analysis of the type, and region. The China market data on skin care and treatment can be segmented by type: functional skincare, medical dressing, general skincare. The general skincare segment held the largest share of the China skin care and treatment market in 2022 and is anticipated to hold its share during the forecast period. Skin care and treatment market is further segmented by region: North China, Northeast China, East China, South Central China, Southwest China, Northwest China.
The functional skincare market is further segmented into recombinant collagen, animal -derived collagen, hyaluronic acid, active ingredients from plants, others. Among these, active ingredients from plants segment occupied the largest market share in 2022. However, the recombinant collagen segment is expected to display the highest CAGR during the forecast period. Furthermore, the medical dressing market has been categorized into recombinant collagen, animal -derived collagen, hyaluronic acid, others. Among them, recombinant collagen segment is projected to grow at the highest CAGR during the forecast period.
Major Companies and Competitive Landscape
The China skin care and treatment market is highly competitive. The report also includes the profiles of leading companies such as Yunnan Botanee Bio-technology Group Co. Ltd., L'Oréal S.A., Bloomage Biotechnology Corp. Ltd., Kao Corporation, Harbin Fuerjia Technology Co. Ltd., Allmed Medical Products Co. Ltd., Guangzhou Trauer Biotechnology Co. Ltd., Winner Medical Co. Ltd.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why Buy This Report?
Get a detailed picture of the China Skin Care and Treatment Market
Identify segments/areas to invest in over the forecast period in the China Skin Care and Treatment Market
Understand the competitive environment, the market's leading players
The market estimate for ease of analysis across scenarios in Excel format
Strategy consulting and research support for three months
Print authentication provided for the single-user license
Request Sample 
Request Discount 
Inquire Before Buy
